Abstract
We conducted a hospital-based case-control study in Peru of 198 women with histologically confirmed cervical cancer (173 squamous cell carcinomas and 25 cases of adenocarcinoma/adenosquamous carcinoma) and 196 control women. Information on risk factors was obtained by personal interview. Using PCR-based assays on exfoliated cervical cells and biopsy specimens, HPV DNA was detected in 95.3% of women with squamous cell carcinoma and in 92.0% of women with adenocarcinoma/adenosquamous carcinoma compared with 17.7% in control women. The age-adjusted odds ratio was 116.0 (95% Cl = 48.6–276.0) for squamous cell carcinoma and 51.4 (95% Cl = 11.4–232.0) for adenocarcinoma/adenosquamous carcinoma. The commonest types in women with cervical cancer were HPV 16, 18, 31, 52 and 35. The association with the various HPV types was equally strong for the two most common types (HPV 16 and 18) as for the other less common types. In addition to HPV, long-term use of oral contraceptives and smoking were associated with an increased risk. HPV is the main cause of both squamous cell carcinoma and adenocarcinoma in Peruvian women. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Bosch FX, Muñoz N, de Sanjosé S, Navarro C, Moreo P and Ascunce N (1993) Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia. Cancer Epidemiol, Biom Prev 2: 415–422
Bosch FX, Muñoz N, Sanjosé S, Eluf-Neto J, Orfila J, Walboomers J and Shah K (1994) What is relevant in cervical carcinogenesis other than HPV?. Papillomavirus in Human Pathology, Monsonego JChallenges of Modern Medicine 9: 173–181
Breslow NE and Day NE (1980) Statistical methods in cancer research 1, The analysis of case-control studies (IARC Scientific Publications No 32). International Agency for Research on Cancer: Lyon
Chaouki N, Bosch FX, Muñoz N, Meijer CJLM, EI Gueddari B and El Ghazi A (1998) The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer 75: 546–555
Chichareon S, Herrero R, Muñoz N, Walboomers JMM, Jacobs M and Bosch FX (1998) Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 90: 50–57
Coursaget P and Muñoz N (1999) Vaccination against infectious agents associated with human cancer. Cancer Surveys 33: 355–381
Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C and Peto J (2000) Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 88: 1565–1572
de Roda Husman AM, Walboomers JMM, Meijer CJLM, Risse EKJ, Schipper MEI and Helmerhorst TJM (1994) Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes using polymerase chain reaction. Int J Cancer 56: 802–806
Eluf-Neto J, Booth M, Muñoz N, Bosch FX, Meijer CJLM and Walboomers JMM (1994) Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer 69: 114–119
Family Planning Programme (1997) National Plan for Gynaecological Cancer Prevention, unpublished report, Ministry of Health: Lima, Peru
Higgins DG and Sharp PH (1988) Clustal: a package for performing sequence alignment on a microcomputer. Gene 73: 237–244
IARC (1998) Globocan I, Cancer Incidence and Mortality Worldwide (IARC Cancer Base No 3). International Agency for Research on Cancer: Lyon
Jacobs MV, de Roda Husman AM, van den Brule AJC, Snijders PJF, Meijer CJLM and Walboomers JMM (1995) Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 33: 901–905
Lacey JV Jr, Brinton LA, Abbas FM, Barnes WA, Gravitt PE and Greenberg MD (1999) Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 8: 1079–1085
Mittal R, Pater A and Pater MM (1993) Multiple human papillomavirus type 16 glucocorticoid response elements functional for transformation, transient expression, and DNA-protein interactions. J Virol 67: 5656–5659
Muñoz N, Bosch FX, de Sanjosé S, Tafur L, Izarzugaza I and Gili M (1992) The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int J Cancer 52: 743–749
Muñoz N, Bosch FX, de Sanjosé S, Vergara A, del Moral A, Muñoz MT and Tafur L (1993) Risk factors for cervical intraepithelial neoplasia grade III/carcinoma in situ in Spain and Colombia. Cancer Epidemiol Biomark Prev 2: 423–431
Ngelangel C, Muñoz N, Bosch FX, Limson GM, Festin MR and Deacon J (1998) The causes of cervical cancer in the Philippines: a case-control study. J Natl Cancer Inst 90: 43–49
Rolón PA, Smith JS, Muñoz N, Klug SJ, Herrero R and Bosch FX (2000) Human papillomavirus infection and invasive cervical cancer in Paraguay. Int J Cancer 85: 486–491
Schiffman M, Herrero R, Hildesheim A, Sherman M, Bratti M and Wacholder S (2000) HPV DNA testing in cervical cancer screening. Results from women in a high-risk province of Costa Rica. J Am Med Assoc 283: 87–93
Szarewski A and Cuzick J (1998) Smoking and cervical neoplasia: a review of the evidence. J Epidemiol Biostat 3: 229–256
Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA and Shah KV (1999) Human papillomavirus, a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12–19
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Santos, C., Muñoz, N., Klug, S. et al. HPV types and cofactors causing cervical cancer in Peru. Br J Cancer 85, 966–971 (2001). https://doi.org/10.1054/bjoc.2001.1948
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2001.1948
Keywords
This article is cited by
-
Frequency and coinfection between genotypes of human papillomavirus in a population of asymptomatic women in northern Peru
BMC Research Notes (2018)
-
Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile
BMC Cancer (2017)
-
Human papillomavirus genotypes distribution in cervical cancer cases in Gabon
Infectious Agents and Cancer (2016)
-
Herpes simplex virus type 2 and the risk of cervical cancer: a meta-analysis of observational studies
Archives of Gynecology and Obstetrics (2014)
-
HLA-B*6701 as a subtype performing post-selected marking gene for cervical cancer
Wuhan University Journal of Natural Sciences (2010)